Literature DB >> 20164286

Application of an improved enzyme-linked immunosorbent assay method for serological diagnosis of canine leishmaniasis.

Nuno Santarém1, Ricardo Silvestre, Luís Cardoso, Henk Schallig, Steven G Reed, Anabela Cordeiro-da-Silva.   

Abstract

Accurate diagnosis of canine leishmaniasis (CanL) is essential toward a more efficient control of this zoonosis, but it remains problematic due to the high incidence of asymptomatic infections. In this study, we present data on the development of enzyme-linked immunosorbent assay (ELISA)-based techniques for the detection of antibodies against the recombinant protein Leishmania infantum cytosolic tryparedoxin peroxidase (LicTXNPx) and a comparison of the results with those employing soluble Leishmania antigens from promastigote or amastigote forms and the homologue recombinant protein L. infantum mitochondrial TXNPx (LimTXNPx). Moreover, we offer an evaluation of the diagnostic potential of rK39 for CanL in the Portuguese canine population and propose an improvement to the existing ELISA-based serological techniques by combining the LicTXNPx and rK39 antigens as a Leishmania antigen mixture (LAM). The data demonstrated that ELISAs based on soluble promastigote or amastigote antigens had generally higher levels of sensitivity for detection of antibodies in symptomatic or asymptomatic dogs than for detection of those against isolated recombinant proteins. Nevertheless, the specificities were found to be similar for all target antigens used. Importantly, the LAM-ELISA methodology improved the overall sensitivity, maintaining a high overall level of specificity. In addition, it was demonstrated that the detection of anti-LAM IgG2 can increase the accuracy of the serological diagnosis. Overall, the obtained results showed that the strategy of combining two well-defined Leishmania antigens, LicTXNPx and rK39, proved to be a sensitive and specific improvement to current serological diagnosis of CanL, being a useful tool for the detection of both clinical and subclinical forms of canine Leishmania infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20164286      PMCID: PMC2863945          DOI: 10.1128/JCM.02402-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  40 in total

1.  Quantitative nucleic acid sequence-based assay as a new molecular tool for detection and quantification of Leishmania parasites in skin biopsy samples.

Authors:  Wendy F van der Meide; Gerard J Schoone; William R Faber; Jim E Zeegelaar; Henry J C de Vries; Yusuf Ozbel; Rudy F M Lai A Fat; Leíla I A R C Coelho; Masoom Kassi; Henk D F H Schallig
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

Review 2.  Applications of molecular methods for Leishmania control.

Authors:  Sarman Singh; Ayan Dey; Ramu Sivakumar
Journal:  Expert Rev Mol Diagn       Date:  2005-03       Impact factor: 5.225

3.  Axenically cultured amastigote forms as an in vitro model for investigation of antileishmanial agents.

Authors:  D Sereno; J L Lemesre
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

4.  Evaluation of the Leishmania recombinant K39 antigen as a diagnostic marker for canine leishmaniasis and validation of a standardized enzyme-linked immunosorbent assay.

Authors:  A Scalone; R De Luna; G Oliva; L Baldi; G Satta; G Vesco; W Mignone; C Turilli; R R Mondesire; D Simpson; A R Donoghue; G R Frank; L Gradoni
Journal:  Vet Parasitol       Date:  2002-04-02       Impact factor: 2.738

Review 5.  Leishmaniasis.

Authors:  B L Herwaldt
Journal:  Lancet       Date:  1999-10-02       Impact factor: 79.321

6.  Comparison between quantitative nucleic acid sequence-based amplification, real-time reverse transcriptase PCR, and real-time PCR for quantification of Leishmania parasites.

Authors:  Wendy van der Meide; Jorge Guerra; Gerard Schoone; Marit Farenhorst; Leíla Coelho; William Faber; Inge Peekel; Henk Schallig
Journal:  J Clin Microbiol       Date:  2007-10-24       Impact factor: 5.948

7.  Visceral leishmaniasis in large Brazilian cities: challenges for control.

Authors:  Claudia Di Lorenzo Oliveira; Maria Helena Franco Morais; George Luiz Lins Machado-Coelho
Journal:  Cad Saude Publica       Date:  2008-12       Impact factor: 1.632

8.  Use of ELISA employing Leishmania (Viannia) braziliensis and Leishmania (Leishmania) chagasi antigens for the detection of IgG and IgG1 and IgG2 subclasses in the diagnosis of American tegumentary leishmaniasis in dogs.

Authors:  Flávia Coelho Ribeiro; Armando de O Schubach; Eliame Mouta-Confort; Tânia M P Schubach; Maria de Fátima Madeira; Mauro C A Marzochi
Journal:  Vet Parasitol       Date:  2007-08-06       Impact factor: 2.738

Review 9.  Immunodiagnosis of parasitic diseases with synthetic peptides.

Authors:  O Noya; M E Patarroyo; F Guzmán; B Alarcón de Noya
Journal:  Curr Protein Pept Sci       Date:  2003-08       Impact factor: 3.272

Review 10.  Complexities of assessing the disease burden attributable to leishmaniasis.

Authors:  Caryn Bern; James H Maguire; Jorge Alvar
Journal:  PLoS Negl Trop Dis       Date:  2008-10-29
View more
  16 in total

Review 1.  Peroxiredoxins in parasites.

Authors:  Michael C Gretes; Leslie B Poole; P Andrew Karplus
Journal:  Antioxid Redox Signal       Date:  2012-01-25       Impact factor: 8.401

2.  A cross-sectional study on canine Leishmania (L.) infantum chagasi infection in Amazonian Brazil ratifies a higher prevalence of specific IgG-antibody response than delayed-type hypersensitivity in symptomatic and asymptomatic dogs.

Authors:  Fernando T Silveira; Liliane A Carneiro; Patrícia K S Ramos; Eugênia J Chagas; Luciana V R Lima; Marliane B Campos; Márcia D Laurenti; Claudia M C Gomes; Carlos E P Corbett
Journal:  Parasitol Res       Date:  2012-06-16       Impact factor: 2.289

3.  Proteins Selected in Leishmania (Viannia) braziliensis by an Immunoproteomic Approach with Potential Serodiagnosis Applications for Tegumentary Leishmaniasis.

Authors:  Mariana C Duarte; Daniel C Pimenta; Daniel Menezes-Souza; Rubens D M Magalhães; João L C P Diniz; Lourena E Costa; Miguel A Chávez-Fumagalli; Paula S Lage; Daniela C Bartholomeu; Maria Julia M Alves; Ana Paula Fernandes; Manuel Soto; Carlos A P Tavares; Denise U Gonçalves; Manoel O C Rocha; Eduardo A F Coelho
Journal:  Clin Vaccine Immunol       Date:  2015-09-16

4.  Development of a fluorescent based immunosensor for the serodiagnosis of canine leishmaniasis combining immunomagnetic separation and flow cytometry.

Authors:  Susana Sousa; Luís Cardoso; Steven G Reed; Alexandre B Reis; Olindo A Martins-Filho; Ricardo Silvestre; Anabela Cordeiro da Silva
Journal:  PLoS Negl Trop Dis       Date:  2013-08-22

5.  Identification of proteins in promastigote and amastigote-like Leishmania using an immunoproteomic approach.

Authors:  Vinicio T S Coelho; Jamil S Oliveira; Diogo G Valadares; Miguel A Chávez-Fumagalli; Mariana C Duarte; Paula S Lage; Manuel Soto; Marcelo M Santoro; Carlos A P Tavares; Ana Paula Fernandes; Eduardo A F Coelho
Journal:  PLoS Negl Trop Dis       Date:  2012-01-17

6.  Improved canine and human visceral leishmaniasis immunodiagnosis using combinations of synthetic peptides in enzyme-linked immunosorbent assay.

Authors:  Míriam Maria Costa; Marcos Penido; Mariana Silva dos Santos; Daniel Doro; Eloísa de Freitas; Marilene Susan Marques Michalick; Gabriel Grimaldi; Ricardo Tostes Gazzinelli; Ana Paula Fernandes
Journal:  PLoS Negl Trop Dis       Date:  2012-05-22

7.  Serological diagnosis of canine leishmaniosis: comparison of three commercial ELISA tests (Leiscan, ID Screen and Leishmania 96), a rapid test (Speed Leish K) and an in-house IFAT.

Authors:  Laia Solano-Gallego; Sergio Villanueva-Saz; Marta Carbonell; Michele Trotta; Tommaso Furlanello; Alda Natale
Journal:  Parasit Vectors       Date:  2014-03-24       Impact factor: 3.876

8.  Mapping B-cell epitopes for the peroxidoxin of Leishmania (Viannia) braziliensis and its potential for the clinical diagnosis of tegumentary and visceral leishmaniasis.

Authors:  Daniel Menezes-Souza; Tiago Antônio de Oliveira Mendes; Ronaldo Alves Pinto Nagem; Thaís Teodoro de Oliveira Santos; Ana Luíza Teixeira Silva; Marcelo Matos Santoro; Silvio Fernando Guimarães de Carvalho; Eduardo Antônio Ferraz Coelho; Daniella Castanheira Bartholomeu; Ricardo Toshio Fujiwara
Journal:  PLoS One       Date:  2014-06-12       Impact factor: 3.240

9.  Improving serodiagnosis of human and canine leishmaniasis with recombinant Leishmania braziliensis cathepsin l-like protein and a synthetic peptide containing its linear B-cell epitope.

Authors:  Daniel Menezes-Souza; Tiago Antônio de Oliveira Mendes; Matheus de Souza Gomes; Daniella Castanheira Bartholomeu; Ricardo Toshio Fujiwara
Journal:  PLoS Negl Trop Dis       Date:  2015-01-08

10.  Serological and infection statuses of dogs from a visceral leishmaniasis-endemic area.

Authors:  Daniela Farias Laranjeira; Vânia Lúcia Ribeiro da Matta; Thaíse Yumie Tomokane; Mary Marcondes; Carlos Eduardo Pereira Corbet; Márcia Dalastra Laurenti
Journal:  Rev Saude Publica       Date:  2014-08       Impact factor: 2.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.